Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
732
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Assessing control bundles for Clostridium difficile: a review and mathematical model

Laith YakobThe University of Queensland, School of Population Health, Herston 4006, AustraliaCorrespondence[email protected]
,
Thomas V RileyThe University of Western Australia, School of Pathology and Laboratory Medicine, Crawley 6009, Australia
,
David L PatersonThe University of Queensland, Centre of Clinical Research, Herston 4029, Australia
,
John MarquessThe University of Queensland, School of Population Health, Herston 4006, Australia
&
Archie CA ClementsThe Australian National University, Research School of Population Health, Canberra 0200, Australia
Pages 1-8 | Received 15 Jan 2014, Accepted 17 Apr 2014, Published online: 25 Jan 2019

  • McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996–2003. Emerg Infect Dis2006; 12: 409–415.
  • Wilcox MH, Smyth ET. Incidence and impact of Clostridium difficile infection in the UK. J Hosp Infect1998; 39: 181–187.
  • Lo Vecchio A, Zacur G. Clostridium difficile infection: an update on epidemiology, risk factors, and therapeutic options. Curr Opin Gastroenterol2012; 28: 1–9.
  • Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol2005; 26: 273–280.
  • Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg2007; 142: 624–631.
  • McGlone SM, Bailey RR, Zimmer SM et al. The economic burden of Clostridium difficile. Clin Microbiol Infect2012; 18: 282–289.
  • He M, Miyajima F, Roberts P et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet2012; 45: 109–113.
  • Garcia C, Samalvides F, Vidal M, Gotuzzo E, Dupont HL. Epidemiology of Clostridium difficile–associated diarrhea in a peruvian tertiary care hospital. Am J Trop Med Hyg2007; 77: 802–805.
  • Dhawan B, Chaudhry R, Sharma N. Incidence of Clostridium difficile infection: a prospective study in an Indian hospital. J Hosp Infect1999; 43: 275–280.
  • Fernandez-Canigia L, Nazar J, Arce M et al. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina.] Rev Argent Microbiol2001; 33: 101–107. Spanish.
  • Herrera P, Cotera A, Fica A, Galdo T, Alvo M. [High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases.] Rev Med Chil2003; 131: 397–403. Spanish.
  • Sadeghifard N, Salari MH, Grassemi MR et al. Prevalence of Clostridium difficile-associated diarrhea in hospitalized patients with nosocomial diarrhea. Iran J Public Health2005; 34: 67–72.
  • Benson L, Song X, Campos J, Singh N. Changing epidemiology of Clostridium difficile-associated disease in children. Infect Control Hosp Epidemiol2007; 28: 1233–1235.
  • Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk—four states, 2005. MMWR Morb Mortal Wkly Rep2005; 54: 1201–1205.
  • Lanzas C, Dubberke ER, Lu Z, Reske KA, Gröhn YT. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect Control Hosp Epidemiol2011; 32: 553–561.
  • Starr JM, Campbell A. Mathematical modelling of Clostridium difficile infection. Clin Microbiol Infect2001; 7: 432–437.
  • Starr JM, Campbell A, Renshaw E, Poxton IR, Gibson GJ. Spatio-temporal stochastic modelling of Clostridium difficile. J Hosp Infect2009; 71: 49–56.
  • Rubin MA, Jones M, Leecaster M et al. A Simulation-based assessment of strategies to control Clostridium difficile transmission and infection. PLoS ONE2013; 8: e80671.
  • Rebmann T, Carrico RM. Preventing Clostridium difficile infections: an executive summary of the Association for Professionals in Infection Control and Epidemiology’s elimination guide. Am J Infect Control2011; 39: 239–242.
  • Weber DJ, Anderson DJ, Sexton DJ, Rutala WA. Role of the environment in the transmission of Clostridium difficile in health care facilities. Am J Infect Control2013; 41: S105–S110.
  • Owens RC, Donskey CJ, Gaynes RP, Loo VG, Muto CA. Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008, 2008; 46: S19–S31.
  • Gerding DN, Johnson S, Peterson LR, Mulligan ME, Silva J. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol1995; 16: 459–477.
  • Health Protection Agency. Clostridium difficile: findings and recommendations from a review of the epidemiology and a survey of directors of infection prevention and control in England. London: HPA, 2006. Available at http://www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1194947403482 (accessed 29 April 2014).
  • Siegel JD, Rhinehart E, Jackson M, Chiarello L; the Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta, GA: CDC, 2007. Available at http://www.cdc.gov/hicpac/pdf/isolation/isolation2007.pdf (accessed 29 April 2014).
  • Yakob L, Riley T, Paterson D, Clements A. Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model. BMC Infect Dis2013; 13: 376.
  • Bignardi GE. Risk factors for Clostridium difficile infection. J Hosp Infect1998; 40: 1–15.
  • Rouphael NG, O’Donnell JA, Bhatnagar J et al. Clostridium difficile-associated diarrhea: an emerging threat to pregnant women. Am J Obst Gynecol2008; 198: 635.e1–6.
  • Clements ACA, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis2010; 10: 395–404.
  • Johnson S, Clabots CR, Linn FV et al. Nosocomial Clostridium difficile colonisation and disease. Lancet1990; 336: 97–100.
  • Loo VG, Bourgault AM, Poirier L et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med2011; 365: 1693–1703.
  • MacDougall C, Polk RE. Variability in rates of use of antibacterials among 130 US hospitals and risk—adjustment models for interhospital comparison. Infect Control Hosp Epidemiol2008; 29: 203–211.
  • Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis2007; 44: 664–670.
  • The Organisation for Economic Co-operation and Development. Health at a glance2011. Paris: OECD, 2011. Available at http://dx.doi.org/10.1787/health_glance-2011-en (accessed 29 April 2014).
  • Rafii F, Sutherland JB, Cerniglia CE. Effects of treatment with antimicrobial agents on the human colonic microflora. Ther Clin Risk Manag2008; 4: 1343–1358.
  • McFarland LV. Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections. Anaerobe2009; 15: 274–280.
  • Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis2011; 53: 994–1002.
  • Bartlett JG. Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis1984; 6 (S1): S235–S241.
  • Centers for Disease Control and Prevention. Frequently asked questions about Clostridium difficile for healthcare providers 2010. Atlanta, GA: CDC, 2010. Available at: http://www.cdc.gov/hai/organisms/cdiff/cdiff_faqs_hcp.html (accessed 29 April 2014).
  • Khanna S, Pardi D, Aronson S et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol2012; 107: 89–95.
  • McFarland LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol2008; 5: 40–48.
  • Leffler DA, Lamont JT. Treatment of Clostridium difficile-associated disease. Gastroenterol2009; 136: 1899–1912.
  • Keeling M, Rohani P. Modeling infectious diseases in humans and animals. Princeton, NJ: Princeton University Press, 2008.
  • Gillespie DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem1977; 81: 2340–2361.
  • Johnson S. Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect2009; 58: 403–410.
  • Delgado-Rodríguez M, Bueno-Cavanillas A, López-Gigosos R et al. Hospital stay length as an effect modifier of other risk factors for nosocomial infection. Eur J Epidemiol1990; 6: 34–39.
  • Freeman J, McGowan JE. Risk factors for nosocomial infection. J Infect Dis1978; 138: 811–819.
  • Goldenberg JZ, Ma SS, Saxton JD et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev2013; 5: CD006095.
  • Muto CA, Blank MK, Marsh JW et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive “bundle” approach. Clin Infect Dis2007; 45: 1266–1273.
  • Weiss K, Boisvert A, Chagnon M et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol2009; 30: 156–162.
  • Abbett SK, Yokoe DS, Lipsitz SR et al. Original article: proposed checklist of hospital interventions to decrease the incidence of healthcare-associated Clostridium difficile infection. Infect Control Hosp Epidemiol2009; 30: 1062–1069.
  • Salgado CD, Mauldin PD, Fogle PJ, Bosso JA. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control2009; 37: 458–464.
  • Koll BS, Ruiz RE, Calfee DP et al. Prevention of hospital-onset Clostridium difficile infection in the New York Metropolitan Region using a collaborative intervention model. J Health Qual2014; 36: 35–45.
  • Bishop J, Parry MF, Hall T. Decreasing Clostridium difficile infections in surgery: impact of a practice bundle incorporating a resident rounding protocol. Conn Med2013; 77: 69–75.
  • Bauer MP, Notermans DW, van Benthem BH et al. First results of the European Clostridium difficile Infection Survey (ECDIS). 19th European Congress of Clinical Microbiology and Infectious Diseases; 16–19 May 2009; Helsinki, Finland.
  • Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev2008; 1: CD004611.
  • Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet1989; 1: 1156–1160.
  • Aldeyab MA, Kearney MP, Scott MG et al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother2012; 67: 2988–2996.
  • Jump RL, Olds DM, Seifi N et al. Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use. Infect Control Hosp Epidemiol2012; 33: 1185–1192.
  • Nathwani D, Sneddon J, Malcolm W et al. Scottish Antimicrobial Prescribing Group (SAPG): development and impact of the Scottish National Antimicrobial Stewardship Programme. Int J Antimicrob Agents2011; 38: 16–26.
  • Valiquette L, Cossette B, Garant MP, Diab H, Pépin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis2007; 45 (S2): S112–S121.
  • Eyre DW, Cule ML, Wilson DJ et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med2013; 369: 1195–1205.
  • Khanna S, Pardi DS, Aronson SL et al. The epidemiology of community acquired Clostridium difficile infection: a population based study. Am J Gastroenterol2012; 13: 89–95.
  • Yakob L, Clements AC. A mathematical model of chikungunya dynamics and control: the major epidemic on Réunion Island. PLoS ONE2013; 8: e57448.
  • Yakob L, Dunning R, Yan G. Indoor residual spray and insecticide-treated bednets for malaria control: theoretical synergisms and antagonisms. J Roy Soc Interface2011; 8: 799–806.
  • Ferguson N, Keeling MJ, Edmunds WJ et al. Planning for smallpox outbreaks. Nature1991; 425: 681–685.
  • Meyers LA. Contact network epidemiology: bond percolation applied to infectious disease prediction and control. Bull Am Math Soc2007; 44: 63–86.
  • Simor AE, Bradley SF, Strausbaugh LJ et al. Clostridium difficile in long-term-care facilities for the elderly. Infect Control Hosp Epidemiol2002; 23: 696–703.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.